Goldman Sachs’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-361,400
| Closed | -$20.4M | – | 6437 |
|
|
2020
Q4 | $20.4M | Buy |
361,400
+400
| +0.1% | +$19.7K | 0.01% | 1844 |
|
|
2020
Q3 | $17.5M | Buy |
361,000
+194,000
| +116% | +$10.5M | 0.01% | 1831 |
|
|
2020
Q2 | $9.29M | Buy |
167,000
+98,500
| +144% | +$5.7M | ﹤0.01% | 2330 |
|
|
2020
Q1 | $3.47M | Buy |
68,500
+61,500
| +879% | +$4.12M | ﹤0.01% | 2923 |
|
|
2019
Q4 | $541K | Sell |
7,000
-94,000
| -93% | -$6.64M | ﹤0.01% | 4465 |
|
|
2019
Q3 | $6.4M | Sell |
101,000
-11,400
| -10% | -$713K | ﹤0.01% | 2673 |
|
|
2019
Q2 | $6.58M | Buy |
+112,400
| New | +$6.63M | ﹤0.01% | 2650 |
|
|
2018
Q3 | – | Sell |
-7,400
| Closed | -$386K | – | 5846 |
|
|
2018
Q2 | $386K | Sell |
7,400
-70,000
| -90% | -$3.67M | ﹤0.01% | 4654 |
|
|
2018
Q1 | $4.04M | Buy |
+77,400
| New | +$3.92M | ﹤0.01% | 3066 |
|
|
2017
Q4 | – | Sell |
-12,600
| Closed | -$699K | – | 6740 |
|
|
2017
Q3 | $699K | Buy |
+12,600
| New | +$834K | ﹤0.01% | 4863 |
|
|
2017
Q2 | – | Sell |
-20,000
| Closed | -$1.49M | – | 7037 |
|
|
2017
Q1 | $1.49M | Hold |
20,000
| – | – | ﹤0.01% | 4025 |
|
|
2016
Q4 | $1.35M | Buy |
+20,000
| New | +$1.29M | ﹤0.01% | 4200 |
|
|
2015
Q3 | – | Sell |
-49,500
| Closed | -$2.35M | – | 7540 |
|
|
2015
Q2 | $2.35M | Buy |
+49,500
| New | +$2.31M | ﹤0.01% | 3678 |
|
Other funds holding NUVA
Goldman Sachs's NUVA Position: Q3 2023 in Review
Goldman Sachs sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 961,190 shares — an estimated $40M sold.
Goldman Sachs first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $166M in Q2 2017. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Goldman Sachs reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Goldman Sachs sold 961,190 NuVasive, Inc. shares in Q3 2023, an estimated $40M.
- Goldman Sachs first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
- Goldman Sachs's NuVasive, Inc. position peaked at $166M in Q2 2017.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.